Please assess the completion status of the following clinical trial:

Trial Title: Prucalopride in Paediatric Subjects, With Functional Faecal Retention

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Subject completed the PRU-USA-12 pharmacokinetic trial~* Subject bowels had been cleaned-out (ie, any faecal impactions removed)~* Written informed consent, signed by the subject's legal guardian and by the investigator~* Subject assent documented in the form of a note-to-file in the subject's source documentation~Exclusion Criteria:~• No exclusion criteria

- Gender: None
- Minimum Age: 4 Years
- Maximum Age: 12 Years
- Healthy Volunteers: None

Study Arms:
- prucalopride (Type: ACTIVE_COMPARATOR): 0.01 mg/kg/day to 0.03 mg/kg/day prucalopride (R108512) oral solution

Based on this trial design, predict the completion outcome and termination type (if applicable).